Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (6): 1234-1237. doi: 10.19723/j.issn.1671-167X.2022.06.030

Previous Articles     Next Articles

朝焰 徐,长艺 林*(),达梅 叶,培埕 吴,明辉 宋,有添 刘,琼 邓,雪艳 黄,忠晓 范,雪兰 游   

  • Received:2021-08-18 Online:2022-12-18 Published:2022-12-19
  • Contact: 长艺 林 E-mail:charmyarn@sina.com

RICH HTML

   

PDF (PC)

CLC Number: 

  • R593.2

Table 1

Demographic, clinical and laboratory data in two groups"

Items Group A Group B P value
Demographic data
  Age/years, M(Min, Max) 63 (20, 82) 50 (43, 75) 0.122
  Male 57.1% (12/21) 41.7% (5/12) 0.481
Clinical presentation
  Duration/d, M(Min, Max) 30 (2, 730) 5 (12, 75) 0.853
  Fever 23.8% (5/21) 33.3% (4/12) 0.699
  Joint swelling 75.0% (18/24) 78.6% (11/14) 1.000
  Joint heating sensation 50% (12/24) 57.1% (8/14) 0.745
  Limitation of joint motion 54.2% (13/24) 64.3% (9/14) 0.735
Laboratory findings
  WBC/mm3, M(Min, Max) 8 600 (2 400, 17 200) 7 900 (3 800, 19 600) 0.554
  ESR/(mm/h), M(Min, Max) 65.0 (1, 133) 88.5 (26, 140) 0.818
  CRP/(mg/L), M(Min, Max) 63.5 (0.8, 295.0) 20.8 (3.6, 213.0) 0.818

Figure 1

Sites of infected joint in two groups"

Table 2

Comorbidities and potential risk factors for infection in two groups"

Items Group A (n=21) Group B (n=12) P value
Glucocorticoid and immunosuppressant use, n(%) 9 (42.9) 5 (41.7) 1.000
Rheumatic and immune diseases, n(%) 7 (33.3) 4 (33.3) 0.723
Diabetes mellitus, n(%) 3 (14.3) 4 (33.3) 0.377
Solid cancer, n(%) 2 (9.5) 1 (8.3) 1.000
Intra-articular injection, n(%) 5 (23.8) 2 (16.7) 1.000
Skin disease, n(%) 3 (14.3) 2 (16.7) 1.000
Cacotrophy, n(%) 7 (33.3) 3 (25.0) 0.710
Other chronic disease, n(%) 10 (47.6) 6 (50.0) 1.000
1 Hassan AS , Rao A , Manadan AM , et al. Peripheral bacterial septic arthritis: Review of diagnosis and management[J]. J Clin Rheumatol, 2017, 23 (8): 435- 442.
doi: 10.1097/RHU.0000000000000588
2 Ross JJ . Septic arthritis of native joints[J]. Infect Dis Clin N Am, 2017, 31 (2): 203- 218.
doi: 10.1016/j.idc.2017.01.001
3 Gupta MN , Sturrock RD , Field M . Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis[J]. Ann Rheum Dis, 2003, 62 (4): 327- 331.
doi: 10.1136/ard.62.4.327
4 Newman JH . Review of septic arthritis throughout the antibiotic era[J]. Ann Rheum Dis, 1976, 35 (5): 198- 205.
5 Lee Y , Cho YS , Sohn YJ , et al. Clinical characteristics and causative pathogens of infective arthritis and risk factors for gram-negative bacterial infections[J]. Infect Chemother, 2020, 52 (4): 503- 515.
doi: 10.3947/ic.2020.52.4.503
6 Mathews CJ , Weston VC , Jones A , et al. Bacterial septic arthritis in adults[J]. Lancet, 2010, 375 (8): 846- 855.
7 Horowitz DL , Katzapa E . Approach to septic arthritis[J]. Am Fam Physician, 2011, 84 (6): 653- 660.
8 Lama V , Theyyunni N . Septic arthritis due to non-tuberculous mycobacterium without effusion[J]. J Am Emerg Med, 2021, 287 (43): e5- e7.
9 Eberst-Ledoux J , Tournadre A , Mathieu S , et al. Septic arthritis with negative bacteriological findings in adult native joints: A retrospective study of 74 cases[J]. Joint Bone Spine, 2012, 79 (2): 156- 159.
doi: 10.1016/j.jbspin.2011.04.019
10 Paosong S , Narongroeknawin P , Pakchotanon R , et al. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis[J]. Int J Rheum Dis, 2015, 18 (3): 353- 359.
11 Shen CJ , Wu MS , Lin KH , et al. The use of procalcitonin in the diagnosis of bone and joint infections: A systematic review and meta-analysis[J]. Eur J Clin Microbiol Infect Dis, 2013, 32 (6): 807- 814.
doi: 10.1007/s10096-012-1812-6
[1] Jiayi TIAN, Yixue GUO, Xia ZHANG, Xiaolin SUN, Jing HE. Flow cytometry analysis of normal range of natural killer cells and their subsets in peripheral blood of healthy Chinese adults [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 839-844.
[2] Yushu YANG, Xuan QI, Meng DING, Wei WANG, Huifang GUO, Lixia GAO. Diagnostic values of anti-salivary gland protein-1 antibody combined with anti-parotid secretory protein antibody for Sjögren's syndrome [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 845-852.
[3] Hua ZHONG, Yuan LI, Liling XU, Mingxin BAI, Yin SU. Application of 18F-FDG PET/CT in rheumatic diseases [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 853-859.
[4] Zhihui WU, Mingzhi HU, Qiaoying ZHAO, Fengfeng LV, Jingying ZHANG, Wei ZHANG, Yongfu WANG, Xiaolin SUN, Hui WANG. Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 860-867.
[5] Dongwu LIU, Jie CHEN, Mingli GAO, Jing YU. Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 928-931.
[6] Zhengfang LI,Cainan LUO,Lijun WU,Xue WU,Xinyan MENG,Xiaomei CHEN,Yamei SHI,Yan ZHONG. Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 729-734.
[7] 佳佳 乔,聪 田,晓波 黄,军 刘. [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 745-749.
[8] Huina HUANG,Jing ZHAO,Xiangge ZHAO,Ziran BAI,Xia LI,Guan WANG. Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 519-525.
[9] Limin REN,Chuchu ZHAO,Yi ZHAO,Huiqiong ZHOU,Liyun ZHANG,Youlian WANG,Lingxun SHEN,Wenqiang FAN,Yang LI,Xiaomei LI,Jibo WANG,Yongjing CHENG,Jiajing PENG,Xiaozhen ZHAO,Miao SHAO,Ru Li. Low disease activity and remission status of systemic lupus erythematosus in a real-world study [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 273-278.
[10] Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283.
[11] Zhanhong LAI,Jiachen LI,Zelin YUN,Yonggang ZHANG,Hao ZHANG,Xiaoyan XING,Miao SHAO,Yuebo JIN,Naidi WANG,Yimin LI,Yuhui LI,Zhanguo LI. A unicenter real-world study of the correlation factors for complete clinical response in idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 284-292.
[12] Yi-jun HAN,Chang-hong LI,Xiu-ying CHEN,Jin-xia ZHAO. Comparison of clinical and immunological characteristics between primary Sjögren's syndrome patients with positive and negative anti-SSB antibody [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1000-1006.
[13] Jian-bin LI,Meng-na LYU,Qiang CHI,Yi-lin PENG,Peng-cheng LIU,Rui WU. Early prediction of severe COVID-19 in patients with Sjögren’s syndrome [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1007-1012.
[14] Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021.
[15] Wen-gen LI,Xiao-dong GU,Rui-qiang WENG,Su-dong LIU,Chao CHEN. Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1022-1027.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd